Clinical trial
The API-CALF Study: Apixaban to Treat Calf Vein Thrombosis
NCT04981327 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The API-CALF Study: Apixaban to Treat Calf Vein Thrombosis
- Lead sponsor
- University Hospital, Geneva
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- September 1, 2022
- Completion date
- August 31, 2027
- Enrollment
- 1,300 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
deep vein thrombosis